# Crescendo Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/crescendo-health

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.crescendo.health
- Total disclosed funding: $3.4M
- Latest round: Seed (Jan 5, 2023)
- Investors on record: 1

## About

Based in California, US, and founded in 2021, Crescendo Health Inc. provides a platform that helps in the collection of patient health data. The company was co-founded by Michael Glassman and Sam Roosz (CEO). In January 2023, the firm raised USD 3.4 million in Seed funding led by investor Define Ventures, with participation from individual investors.

The company offers a platform that digitally collects and stores patient data which is used in clinical research. The process of the firm flows like this first patients have to signup and agrees to share the provided information with the study, then crescendo collects the health record from multiple sources at one place on behalf of the patients. Additionally, the firm provides a secure portal that gives access to all health records of patients as well as shares the required data with patient consent after the removal of their personal identifiers to support the research study. At the end of the study, it is the option for patients to retain their personal health records or delete them.

The company plans to use the January 2023 funding to invest in developing software tools that allow users to research the long-term consequences of treatments and follow the progress of treatments, as well as expand its services throughout the life sciences sector.

## Funding rounds

- Seed, Jan 5, 2023, $3.4M — Define Ventures

## Investors

- Define Ventures (https://capitalatlas.ai/funds/define-ventures) — Seed